Shanghai Shen Lian Biomedical Corporation (SHA:688098)
China
· Delayed Price · Currency is CNY 8.88
-0.05 (-0.56%)
Apr 30, 2026, 9:54 AM CST
SHA:688098 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 3,667 | 3,647 | 2,246 | 3,072 | 3,261 | 4,534 | Upgrade
|
| Market Cap Growth | 53.97% | 62.34% | -26.87% | -5.79% | -28.08% | -31.23% | Upgrade
|
| Enterprise Value | 3,536 | 3,538 | 2,097 | 2,909 | 2,931 | 4,093 | Upgrade
|
| Last Close Price | 8.93 | 8.88 | 5.47 | 7.42 | 7.79 | 10.72 | Upgrade
|
| PE Ratio | - | - | - | 97.45 | 53.36 | 41.14 | Upgrade
|
| PS Ratio | 12.72 | 12.65 | 7.40 | 10.19 | 9.92 | 12.65 | Upgrade
|
| PB Ratio | 2.62 | 2.61 | 1.58 | 2.04 | 2.18 | 3.08 | Upgrade
|
| P/TBV Ratio | 2.90 | 2.88 | 1.72 | 2.20 | 2.26 | 3.14 | Upgrade
|
| P/FCF Ratio | - | - | 504.58 | - | - | - | Upgrade
|
| P/OCF Ratio | 110.86 | 110.24 | 25.14 | 871.25 | 358.76 | 50.31 | Upgrade
|
| EV/Sales Ratio | 12.27 | 12.27 | 6.91 | 9.65 | 8.92 | 11.42 | Upgrade
|
| EV/EBITDA Ratio | 57.42 | 58.20 | 61.42 | 32.02 | 23.54 | 26.59 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 105.02 | 43.38 | 37.11 | Upgrade
|
| EV/FCF Ratio | -290.88 | - | 471.14 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0 | 0 | Upgrade
|
| Debt / EBITDA Ratio | 0.23 | 0.23 | 0.45 | 0.01 | 0.00 | 0.00 | Upgrade
|
| Debt / FCF Ratio | - | - | 3.48 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.10 | -0.10 | -0.12 | -0.14 | -0.24 | -0.32 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.31 | -2.31 | -5.11 | -2.27 | -2.87 | -3.04 | Upgrade
|
| Net Debt / FCF Ratio | 11.57 | 11.57 | -39.21 | 1.63 | 4.25 | 4.77 | Upgrade
|
| Asset Turnover | 0.19 | 0.19 | 0.19 | 0.19 | 0.21 | 0.23 | Upgrade
|
| Inventory Turnover | 1.31 | 1.31 | 1.17 | 0.77 | 0.74 | 1.00 | Upgrade
|
| Quick Ratio | 3.30 | 3.30 | 3.91 | 6.33 | 6.04 | 5.54 | Upgrade
|
| Current Ratio | 4.02 | 4.02 | 4.74 | 7.82 | 7.26 | 6.46 | Upgrade
|
| Return on Equity (ROE) | -1.77% | -1.77% | -3.32% | 1.99% | 4.11% | 7.28% | Upgrade
|
| Return on Assets (ROA) | -0.57% | -0.57% | -1.34% | 1.08% | 2.64% | 4.43% | Upgrade
|
| Return on Invested Capital (ROIC) | -1.11% | -1.13% | -2.64% | 1.87% | 5.15% | 10.08% | Upgrade
|
| Return on Capital Employed (ROCE) | -1.00% | -1.00% | -2.30% | 1.80% | 4.50% | 7.40% | Upgrade
|
| Earnings Yield | -0.56% | -0.56% | -1.99% | 1.03% | 1.87% | 2.43% | Upgrade
|
| FCF Yield | -0.33% | -0.33% | 0.20% | -4.11% | -2.58% | -2.16% | Upgrade
|
| Dividend Yield | - | - | - | 0.47% | 1.03% | - | Upgrade
|
| Payout Ratio | - | - | - | 103.98% | 60.25% | 37.03% | Upgrade
|
| Buyback Yield / Dilution | -0.78% | -0.78% | -3.23% | 3.28% | 0.20% | 2.31% | Upgrade
|
| Total Shareholder Return | -0.78% | -0.78% | -3.23% | 3.75% | 1.23% | 2.31% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.